News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
ADAMS ADRIAN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 07/15/2022 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 15,500 shares
@ $0
Granted 31,000 options to buy
@ $0.2309, valued at
$7.2k
|
|
| 06/09/2022 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $0.45, valued at
$9k
|
|
| 01/28/2022 |
4
| ADAMS ADRIAN (COB, CEO and President) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 175,000 options to buy
@ $9.85, valued at
$1.7M
|
|
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2021 |
4
| ADAMS ADRIAN (COB, CEO and President) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 50,000 options to buy
@ $12.16, valued at
$608k
|
|
| 06/17/2021 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $1.41, valued at
$28.2k
|
|
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/16/2020 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 7,500 shares
@ $0
Granted 15,000 options to buy
@ $1.43, valued at
$21.5k
|
|
| 06/15/2020 |
4/A
| ADAMS ADRIAN (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Bought 100,000 shares
@ $1.289, valued at
$128.9k
|
|
| 06/15/2020 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Bought 100,000 shares
@ $1.289, valued at
$128.9k
|
|
| 06/09/2020 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $11.96, valued at
$240.4k
|
|
| 11/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2019 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 3,750 shares
@ $0
Granted 7,500 options to buy
@ $2.19, valued at
$16.4k
|
|
| 06/10/2019 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $4.23, valued at
$85k
|
|
| 12/13/2018 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $8.94, valued at
$223.5k
|
|
| 12/13/2018 |
3
| ADAMS ADRIAN (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 06/14/2018 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $4.125, valued at
$61.9k
|
|
| 06/15/2017 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $2.3, valued at
$34.5k
|
|
| 05/12/2017 |
4
| ADAMS ADRIAN (CEO) has filed a Form 4 on Aralez Pharmaceuticals Inc. |
| 03/17/2017 |
4
| ADAMS ADRIAN (CEO) has filed a Form 4 on Aralez Pharmaceuticals Inc. |
| 06/22/2016 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $2.87, valued at
$43.1k
|
|
| 03/18/2016 |
4
| ADAMS ADRIAN (CEO) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Granted 124,342 shares
@ $0
Granted 105,251 options to buy
@ $3.8, valued at
$400k
|
|
| 02/09/2016 |
4
| ADAMS ADRIAN (CEO) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Acquired 2,944,888 shares
@ $0 |
|
| 11/12/2015 |
4
| ADAMS ADRIAN (CEO) has filed a Form 4 on POZEN INC /NC|
Txns:
| Bought 551,471 shares
@ $6.4495, valued at
$3.6M
Bought 448,529 shares
@ $6.6792, valued at
$3M
|
|
| 06/24/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/05/2015 |
4
| ADAMS ADRIAN (CEO) has filed a Form 4 on POZEN INC /NC|
Txns:
| Granted 1,944,888 shares
@ $0 |
|
| 01/30/2015 |
4
| ADAMS ADRIAN (CEO and President) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Disposed of 97,644 shares
@ $0
Disposed of 120,134 shares
@ $36.53, valued at
$4.4M
Disposed of 510,000 options to buy
@ $17.4, valued at
$8.9M
Disposed of 129,000 options to buy
@ $17.96, valued at
$2.3M
Disposed of 156,500 options to buy
@ $28.3, valued at
$4.4M
|
|
| 12/08/2014 |
4
| ADAMS ADRIAN (CEO and President) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Sold 40,000 shares
@ $33.9676, valued at
$1.4M
Exercised 40,000 options to buy
@ $17.4, valued at
$696k
|
|
| 07/28/2014 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $10.22, valued at
$153.3k
|
|
| 03/12/2014 |
4/A
| ADAMS ADRIAN (CEO and President) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Granted 51,600 shares
@ $0
Granted 62,500 shares
@ $0 |
|
| 02/20/2014 |
4
| ADAMS ADRIAN (CEO and President) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Granted 23,775 shares
@ $0
Granted 62,500 shares
@ $0
Granted 156,500 options to buy
@ $28.3, valued at
$4.4M
Granted 58,000 options to buy
@ $0 |
|
| 09/16/2013 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Bought 15,000 options to buy
@ $10.55, valued at
$158.3k
|
|
|
|
|